Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer
combination of pemetrexed and cisplatin to treat advanced breast cancer. Previous regimen no
more than 3 which including enthrycycline and taxanes(paclitaxel and/or docetaxel)
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
PFS (progression free survival)
2 Years
Yes
Binghe Xu, M.D.
Study Chair
Chinese Academy of Medical Sciences
China: Ministry of Health
CH-BC-008
NCT01143974
June 2010
June 2012
Name | Location |
---|